Published in Law and Health Weekly, January 3rd, 2009
OmegaGenesis has developed novel methods to safely generate large-scale quantities of the nano-scale europium hydroxide rods, which were first developed at the Mayo Clinic and shown to promote angiogenesis, the formation of new blood vessels. The company has established non-toxicity of the europium hydroxide...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly